MIM
CMRX

MetLife Investment Management’s Chimerix, Inc. CMRX Stock Holding History

MetLife Investment Management’s Portfolio CMRX Stock Details CMRX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q1 		– Sell
-44,657
Closed -$83.1K – 2819
2022
Q4 		$83.1K Buy
+44,657
New +$87.4K ﹤0.01% 2662
2022
Q2 		– Sell
-42,753
Closed -$196K – 2916
2022
Q1 		$196K Buy
42,753
+15,374
+56% +$85.7K ﹤0.01% 2363
2021
Q4 		$176K Buy
27,379
+12,214
+81% +$73.3K ﹤0.01% 2129
2021
Q3 		$93.9K Sell
15,165
-13,374
-47% -$91.9K ﹤0.01% 2467
2021
Q2 		$228K Buy
28,539
+19,978
+233% +$166K ﹤0.01% 2078
2021
Q1 		$82.5K Buy
+8,561
New +$78.6K ﹤0.01% 2261
2018
Q2 		– Sell
-24,342
Closed -$127K – 2230
2018
Q1 		$127K Buy
+24,342
New +$123K ﹤0.01% 2112

Other funds holding CMRX

RCMNY
Rubric Capital Management (New York) New York $9.44B AUM 68.42% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
AC
Armistice Capital New York $5.62B AUM 36.06% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return
MAM
Monaco Asset Management Monaco $1.26B AUM 60.23% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
MP
MSD Partners New York $82.3M AUM 15.13% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $218B AUM 29.41% 1-Year Est. Return

MetLife Investment Management's CMRX Position: Q1 2023 in Review

MetLife Investment Management sold out of Chimerix, Inc. (CMRX) in Q1 2023, closing a stake of 44,657 shares — an estimated $83.1K sold.

MetLife Investment Management first reported a position in CMRX in Q1 2018 and held it in 7 quarters. The position peaked at $228K in Q2 2021. 97 funds tracked by Wall St. Rank hold CMRX as of Q1 2023.

  • MetLife Investment Management reported no remaining Chimerix, Inc. position as of Q1 2023 after selling out during the quarter.
  • MetLife Investment Management sold 44,657 Chimerix, Inc. shares in Q1 2023, an estimated $83.1K.
  • MetLife Investment Management first reported a position in Chimerix, Inc. in Q1 2018 and held it in 7 quarters.
  • MetLife Investment Management's Chimerix, Inc. position peaked at $228K in Q2 2021.
  • 97 funds tracked by Wall St. Rank held Chimerix, Inc. as of Q1 2023.

Based on MetLife Investment Management's 13F filing for Q1 2023, filed 15 May 2023.